Medtronic Investors Sue Over Insulin Pump Recall, FDA Letter
Medtronic was hit with a proposed class action Thursday by a group of pension funds alleging the medical device manufacturer hid that its insulin pumps were defective, causing its stock to...To view the full article, register now.
Already a subscriber? Click here to view full article